ECM
IDXX icon

ETrade Capital Management’s Idexx Laboratories IDXX Stock Holding History

ETrade Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,788
Closed -$611K – 723
2017
Q2 		$611K Buy
3,788
+230
+6% +$37.4K 0.02% 415
2017
Q1 		$550K Sell
3,558
-2,268
-39% -$313K 0.02% 416
2016
Q4 		$683K Buy
5,826
+594
+11% +$67.8K 0.03% 344
2016
Q3 		$590K Buy
5,232
+1,672
+47% +$176K 0.03% 348
2016
Q2 		$331K Buy
+3,560
New +$306K 0.02% 383
2013
Q4 		– Sell
-20
Closed -$1K – 873
2013
Q3 		$1K Buy
+20
New +$961 ﹤0.01% 886

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

ETrade Capital Management's IDXX Position: Q3 2017 in Review

ETrade Capital Management sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 3,788 shares — an estimated $611K sold.

ETrade Capital Management first reported a position in IDXX in Q3 2013 and held it in 6 quarters. The position peaked at $683K in Q4 2016. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • ETrade Capital Management reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
  • ETrade Capital Management sold 3,788 Idexx Laboratories shares in Q3 2017, an estimated $611K.
  • ETrade Capital Management first reported a position in Idexx Laboratories in Q3 2013 and held it in 6 quarters.
  • ETrade Capital Management's Idexx Laboratories position peaked at $683K in Q4 2016.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on ETrade Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.